RX

Progressive Care IncOOTC RXMD Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

RXMD Stock Analysis

RX

Uncovered

Progressive Care Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-2/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

3.347 B

Progressive Care, Inc. is a personalized healthcare services and technology company that provides prescription pharmaceuticals and risk and data management services to healthcare organizations and providers. The company is headquartered in Hallandale Beach, Florida and currently employs 118 full-time employees. The company went IPO on 2008-11-20. The firm provides prescription pharmaceuticals and risk and data management services to healthcare organizations and providers. The firm provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, contracted pharmacy services for 340B Covered Entities under the 340B Drug Discount Pricing Program, and health practice risk management. The company offers a range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive drugs. The firm also provides patient health risk reviews and free same-day delivery. The company obtains pharmaceutical and other products from wholesale drug distributors. The firm sells to a range of customers, including various managed care organizations within both the private and public sectors.

View Section: Eyestock Rating